Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4093 |
Fabomotizole hydrochloride
Afobazole hydrochloride,CM346 hydrochloride |
MAO | Metabolism; Neuroscience |
Fabomotizole hydrochloride (CM346 hydrochloride) 是一种具有抗焦虑和神经保护作用的化合物。 | |||
T1864 |
Fabomotizole
Obenoxazine,CM346,4-(2-(5-乙氧基-1H-苯并[D]咪唑-2-基硫代)乙基)吗啉 |
Others | Others |
Fabomotizole (Obenoxazine) 是一种抗焦虑药物,具有抗焦虑和神经保护作用,且无镇静和肌肉松弛作用。 | |||
T70072 | Aplindore | ||
Aplindore is a dopamine receptor agonist used in the therapeutic treatment of Parkinson's Disease. | |||
T70073 |
Fabomotizole dihydrochloride
|
||
Fabomotizole, also known as Afobazole, Obenoxazine and CM346, is an anxiolytic drug launched in Russia in the early 2000s. It produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. Its mechanism of action remains poorly defined however, with GABAergic, NGF- and BDNF-release-promoting, MT1 receptor agonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Fabomotizole was shown to inhibit MAO-A reversibly and there might be al... |